Raltitrexed degradation impurity and preparation method thereof
Through the series of reaction steps of thiophene-2-carboxylic acid and diphenyl azide phosphate, the degradation of impurities of ratitroxede was prepared, which solved the identification and research problems in the prior art, provided efficient and low-cost impurity reference products, and improved the Quality control and safety of drugs.
Patent Information
- Application Number
- CN202411183679.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-12-03
AI Technical Summary
The failure to effectively identify and study the degraded impurities of ratitroxed in the prior art makes it difficult to control their quality and lack of impurity control products, which affects the safety and effectiveness of the drug.
The impurity intermediate is obtained by reacting thiophene-2-carboxylic acid with diphenyl azide phosphate, followed by upmethylation, deprotection and substitution reactions, and finally the degradation of impurities by crystallization of ethyl acetate is obtained, providing Preparation method and impurity reference.
It realizes efficient preparation of impurities degraded by letitroxed, provides cheap and easy-to-get high-quality impurity reference products, improves the quality control and safety of drugs, fills the technical gap, simplifies the separation and purification process, and reduces costs.
Smart Images

Figure CN119060033A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of chemical synthesis, and particularly relates to a raltitrexed degradation impurity and a preparation method thereof. Background Art
[0002] Raltitrexed, chemical name is N-[5-[N-methyl-N-(2-methyl-4-oxo-3,4-dihydroquinazoline-6-methyl)amino]thiophene-2-carbonyl]-L-glutamic acid, the structural formula is:
[0003]
[0004] Raltitrexed is a quinazoline folate analog. Currently, Raltitrexed is a new type of water-soluble thymidylate synthase inhibitor that can cause DNA breakage and cell death by inhibiting thymidylate synthase. Compared with 5-fluorouracil, Raltitrexed has stronger selectivity and can replace fluorouracil in the treatment of advanced colorectal cancer. It has become a first-line drug for the treatment of advanced colorectal cancer.
[0005] Impurities in APIs mainly come from the degradation and manufacturing process of the API itself. Process impurities include unreacted raw materials, intermediates, reaction by-products, derivatives of impurities contained in raw materials or intermediates, solvents, reagents, catalyst residues used in the reaction process or impurities involved in the reaction, API degradation products, etc.
[0006] In a series of studies conducted by the inventors of the present applicant, it was found that there was an unknown degradation impurity in raltitrexed, which was detected in both the raw materials and the commercially available preparations, but it was not reported in the existing literature, and therefore could not provide an impurity reference for the quality control-related studies of raltitrexed. The inventors dissolved 5g of the finished product of raltitrexed in tetrahydrofuran, added 10ml of 1mol of dilute hydrochloric acid, stirred at 100°C overnight, and took a sample for inspection. The HPLC spectrum was shown in FIG. Figure 1 ,Depend on Figure 1 It can be seen that RT = 39.5min is the peak time of the impurity. Although the impurity can be directly degraded by the degradation of raltitrexate acid, the degradation content is low. The impurity itself is extremely unstable, and there are many and complex impurity peaks around it, making separation and purification extremely difficult.
[0007] Therefore, further identification, research and structural confirmation of the impurities of raltitrexed are of great significance to further improve the level of quality control and safety of raltitrexed. Summary of the invention
[0008] In order to solve the technical problems existing in the prior art, the purpose of the present invention is to provide a degradation impurity of raltitrexed and a preparation method thereof, and to provide an impurity reference substance for the quality control-related research of raltitrexed.
[0009] In order to achieve the above purpose and the above technical effect, the technical solution adopted by the present invention is:
[0010] A raltitrexed degradation impurity, the Chinese name of the raltitrexed degradation impurity is 2-methyl-6-[[(methyl)(thiophen-2-yl)amino]methyl]quinazolin-4(3H)-one, and has the following structure:
[0011]
[0012] The present invention also discloses a method for preparing raltitrexed degradation impurities, comprising the following steps:
[0013]
[0014] S1, using thiophene-2-carboxylic acid as a starting material, reacting with diphenylphosphoryl azide to obtain impurity intermediate-1;
[0015] S2, methylating the impurity intermediate-1 obtained in step S1 to obtain the impurity intermediate-2;
[0016] S3, deprotecting the impurity intermediate-2 obtained in step S2 to obtain the impurity intermediate-3;
[0017] S4, reacting the impurity intermediate-3 obtained in step S3 with compound A to obtain a crude product of degradation impurities;
[0018] S5. The crude product of degraded impurities obtained in step S4 is crystallized with ethyl acetate and filtered to obtain a finished product.
[0019] Furthermore, in step S1, the step of using thiophene-2-carboxylic acid as a starting material and reacting with diphenylphosphoryl azide to obtain impurity intermediate-1 comprises:
[0020] Dissolve thiophene-2-carboxylic acid in tert-butanol, cool to below 25°C and then add alkali dropwise, then add diphenylphosphoryl azide dropwise, then heat to 60-100°C and react for 1-3h, then add purified water after the reaction, cool at 10-20°C and crystallize, then filter to obtain the impurity intermediate-1.
[0021] Furthermore, the weight ratio of thiophene-2-carboxylic acid to tert-butanol is 1:5-10; the base is triethylamine and / or N,N-diisopropylethylamine; the weight ratio of thiophene-2-carboxylic acid to diphenylphosphoryl azide is 1:2-5; the weight ratio of thiophene-2-carboxylic acid to purified water is 1:20-30.
[0022] Furthermore, in step S2, the impurity intermediate-1 obtained in step S1 is subjected to methylation to obtain the impurity intermediate-2, which comprises:
[0023] The impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene and molecular sieves were dissolved in dichloromethane, cooled to 0-15°C and trimethyloxonium tetrafluoroborate was added, and the mixture was reacted at 0-30°C for 2-5h. After the reaction was completed, the mixture was filtered and the filtrate was dried to obtain the impurity intermediate-2.
[0024] Furthermore, the weight ratio of the impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene, molecular sieve, and dichloromethane is 1:2.5-3:1-5:15-25; the weight ratio of the impurity intermediate-1 to trimethyloxonium tetrafluoroborate is 1:1.4-1.8.
[0025] Further, in step S3, the impurity intermediate-2 obtained in step S2 is deprotected to obtain the impurity intermediate-3, comprising:
[0026] Dissolve the impurity intermediate-2 in dichloromethane, cool to 0-10°C, then add acid dropwise, raise the temperature to 10-30°C and react for 1-3 hours. After the reaction is complete, concentrate to obtain the impurity intermediate-3;
[0027] The weight ratio of the impurity intermediate-2 to dichloromethane is 1:5-8;
[0028] The acid is hydrochloric acid and / or trifluoroacetic acid.
[0029] Further, in step S4, the step of reacting the impurity intermediate-3 obtained in step S3 with compound A to obtain a crude degraded impurity product comprises:
[0030] The impurity intermediate-3 was dissolved in N,N-dimethylformamide, the pH of the system was adjusted to 7-8, compound A and a base were added, the temperature was raised to 40-60°C and the reaction was performed for 5-10 hours. After the reaction was completed, purified water and dichloromethane were added for extraction, and the organic phase was concentrated to obtain a crude product of degradation impurities.
[0031] Furthermore, the weight ratio of the impurity intermediate-3, compound A, N,N-dimethylformamide, and base is 1:0.5-1:8-12:0.2-0.5; the weight ratio of the impurity intermediate-3, dichloromethane, and purified water is 1:10-15:10-15; the Chinese name of the compound A is 6-bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one, which has the following structure:
[0032]
[0033] Further, in step S5, the step of crystallizing the crude degradation impurity product obtained in step S4 with ethyl acetate and filtering to obtain the finished product comprises:
[0034] The crude degradation impurity product is dissolved in ethyl acetate, wherein the weight ratio of the crude degradation impurity product to ethyl acetate is 1:5-10, and the product is first refluxed at 70-80°C for 30-60 minutes, then cooled to 20-30°C and pulped for 1-2 hours, and then filtered to obtain the finished product.
[0035] Compared with the prior art, the present invention has the following beneficial effects:
[0036] The invention discloses a raltitrexed degradation impurity and a preparation method thereof. Thiophene-2-carboxylic acid is used as an accessible reaction raw material, a Curtius rearrangement reaction is first performed to obtain an impurity intermediate-1, a methylation reaction is performed on the impurity intermediate-1 to obtain an impurity intermediate-2, a deprotection reaction is performed on the impurity intermediate-2 to obtain an impurity intermediate-3, a substitution reaction is performed on the impurity intermediate-3 and a compound A, and then ethyl acetate is used for crystallization, and raltitrexed degradation impurities of a target structure are obtained by suction filtration. The reaction materials of each step are all accessible materials, which are cheap and easy to obtain, the preparation method is simple and efficient, the yield is high, the preparation cost is low, the reaction is mild, and the process is controllable, so that the preparation of the raltitrexed degradation impurity is accessible, and fills the gap in the preparation of the raltitrexed degradation impurity. The technical gap in the preparation can provide cheap, easy-to-obtain, high-quality impurity reference substances for the quality research of raltitrexed, which is of great significance to the safe use of raltitrexed; by analyzing the source and formation mechanism of degradation impurities of raltitrexed, it is convenient to optimize the reaction conditions, select suitable raw materials and solvents, improve the separation and purification methods, etc., which is conducive to reasonably controlling the content of degradation impurities and reducing the generation of degradation impurities, and is conducive to ensuring that the quality of API meets the standards, thereby improving the safety and effectiveness of drugs, and can facilitate the impurity analysis and research of raltitrexed raw materials and preparations, and provide detection methods and judgment basis for the production and medication safety of raltitrexed raw materials and preparations, which is of great significance to further improve the level and safety of quality control of raltitrexed, and has good practical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 is the HPLC spectrum of impurities degraded from raltitrexed in the prior art;
[0038] Figure 2 A synthetic route diagram of a method for preparing raltitrexed degraded impurities of the present invention;
[0039] Figure 3 HPLC detection spectrum of the degradation impurities prepared in Example 1 of the present invention;
[0040] Figure 4 is a positive ion mode mass spectrum of the degradation impurities prepared in Example 1 of the present invention;
[0041] Figure 5is a negative ion mode mass spectrum of the degraded impurities prepared in Example 1 of the present invention;
[0042] Figure 6 is the NMR carbon spectrum of the degraded impurities prepared in Example 1 of the present invention;
[0043] Figure 7 is the H NMR spectrum of the degraded impurities prepared in Example 1 of the present invention; DETAILED DESCRIPTION
[0044] The present invention is described in detail below so that the advantages and features of the present invention can be more easily understood by those skilled in the art, thereby making a clearer and more definite definition of the protection scope of the present invention.
[0045] A brief summary of one or more aspects is given below to provide a basic understanding of these aspects. This summary is not an exhaustive overview of all conceived aspects, and is neither intended to identify the key or critical elements of all aspects nor to define the scope of any or all aspects. Its only purpose is to give some concepts of one or more aspects in a simplified form as a prelude to a more detailed description that will be given later.
[0046] like Figure 2-7 As shown, the present invention discloses a degradation impurity of raltitrexed, the Chinese name of the degradation impurity of raltitrexed is 2-methyl-6-[[(methyl)(thiophen-2-yl)amino]methyl]quinazolin-4(3H)-one, and has the following structure:
[0047]
[0048] The present invention also discloses a method for preparing raltitrexed degradation impurities, comprising the following steps:
[0049]
[0050] S1. Dissolve thiophene-2-carboxylic acid with tert-butanol, the weight ratio of thiophene-2-carboxylic acid to tert-butanol is 1:5-10, preferably 1:8.33. Cool to below 25°C and then drop a base, the base is triethylamine and / or N,N-diisopropylethylamine. After the drop is complete, drop DPPA (diphenylphosphoryl azide), the weight ratio of thiophene-2-carboxylic acid to DPPA is 1:2-5, preferably 1:2.5. After the drop is complete, heat to 60-100°C, preferably 85°C, and react for 1-3h, preferably 2h. After the reaction is completed, add purified water, the weight ratio of thiophene-2-carboxylic acid to purified water is 1:20-30, preferably 1:23.33. Cool down at 10-20°C for crystallization, and filter to obtain impurity intermediate-1, which has the following structure:
[0051]
[0052] S2, dissolving the impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene and molecular sieve with dichloromethane, wherein the weight ratio of the impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene, molecular sieve and dichloromethane is 1:2.5-3:1-5:15-25, preferably 1:2.7:1:19, cooling to 0-15°C, adding trimethyloxonium tetrafluoroborate, the weight ratio of the impurity intermediate-1 to trimethyloxonium tetrafluoroborate is 1:1.4-1.8, preferably 1:1.49, reacting at 0-30°C (preferably 10-20°C) for 2-5h, preferably 4h, after the reaction is completed, suction filtering, and the filtrate is spin-dried to obtain the impurity intermediate-2, which has the following structure:
[0053]
[0054] S3, dissolving the impurity intermediate-2 with dichloromethane, wherein the weight ratio of the impurity intermediate-2 to dichloromethane is 1:5-8, preferably 1:6, cooling to 0-10°C and then dropping an acid, wherein the acid is hydrochloric acid and / or trifluoroacetic acid, and heating to 10-30°C (preferably 20-25°C) after the dropping is complete, and reacting for 1-3h (preferably 2h), after the reaction is completed, concentrating to obtain the impurity intermediate-3, which has the following structure:
[0055]
[0056] S4, dissolving the impurity intermediate-3 with N,N-dimethylformamide, adjusting the system pH to 7-8 with triethylamine, adding compound A and alkali, raising the temperature to 40-60°C (preferably 50-55°C) and reacting for 5-10h (preferably 6h), adding purified water and dichloromethane for extraction after the reaction, and concentrating the organic phase to obtain a crude product of degradation impurities;
[0057] In this step, the weight ratio of impurity intermediate-3, compound A, N,N-dimethylformamide, and base is 1:0.5-1:8-12:0.2-0.5, preferably 1:0.74:9.40:0.35; the base is an organic base or an inorganic base, selected from one or a combination of 2,6-lutidine, pyridine, triethylamine, N,N-diisopropylethylamine, sodium bicarbonate, potassium carbonate, sodium carbonate, and potassium hydroxide, preferably 2,6-lutidine; the weight ratio of impurity intermediate-3, dichloromethane, and purified water is 1:10-15:10-15, preferably 1:13.50:13.50;
[0058] The Chinese name of compound A is 6-bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one, and has the following structure:
[0059]
[0060] S5, crystallizing the crude product of degradation impurities with ethyl acetate, and filtering to obtain the target product of raltitrexed degradation impurities finished product. Wherein, the weight ratio of the crude product of degradation impurities to ethyl acetate is 1:5-10, preferably 1:6.5, and the specific crystallization steps are:
[0061] The crude degradation impurity product is dissolved in ethyl acetate, first refluxed at 70-80°C for 30-60 min, then cooled to 20-30°C and slurried for 1-2 h, and then filtered to obtain the finished product.
[0062] Example 1
[0063] A method for preparing raltitrexed degraded impurities comprises the following steps:
[0064]
[0065] S1. Dissolve thiophene-2-carboxylic acid with 42g tert-butanol, the weight ratio of thiophene-2-carboxylic acid to tert-butanol is 1:8.33. Cool to 20°C and then drop 7.92g triethylamine. After the drop is complete, add DPPA (diphenylphosphorylazide) dropwise, the weight ratio of thiophene-2-carboxylic acid to DPPA is 1:2.5. After the drop is complete, heat to 85°C and react for 2h. After the reaction is completed, cool to 15°C and add purified water, the weight ratio of thiophene-2-carboxylic acid to purified water is 1:23.33. Cool down at 15°C for 1h to crystallize, and filter to obtain impurity intermediate-1. Impurity intermediate-1 has the following structure:
[0066]
[0067] S2. Dissolve 3g of impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene and 4A molecular sieve in dichloromethane, wherein the weight ratio of impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene, 4A molecular sieve and dichloromethane is 1:2.7:1:19. After cooling to 15°C, add trimethyloxonium tetrafluoroborate, the weight ratio of impurity intermediate-1 to trimethyloxonium tetrafluoroborate is 1:1.49, react at 10°C for 4h, filter after the reaction is completed, and spin-dry the filtrate to obtain impurity intermediate-2. Impurity intermediate-2 has the following structure:
[0068]
[0069] S3, 1g of impurity intermediate-2 was dissolved in dichloromethane, the weight ratio of impurity intermediate-2 to dichloromethane was 1:6, and 3.22g of trifluoroacetic acid was added dropwise after cooling to 10°C, and the temperature was raised to 25°C after the addition was complete to react for 2h. After the reaction was completed, the impurity intermediate-3 was obtained by concentration. The impurity intermediate-3 had the following structure:
[0070]
[0071] S4, dissolve 0.5 g of impurity intermediate-3 with N,N-dimethylformamide, adjust the system pH to 8 with triethylamine, add compound A and 2,6-lutidine, raise the temperature to 50°C and react for 6 hours, add purified water and dichloromethane for extraction after the reaction, and concentrate the organic phase to obtain a crude product of degradation impurities;
[0072] In this step, the weight ratio of impurity intermediate-3, compound A, N,N-dimethylformamide, and 2,6-lutidine is 1:0.74:9.40:0.35; the weight ratio of impurity intermediate-3, dichloromethane, and purified water is 1:13.50:13.50;
[0073] The Chinese name of compound A is 6-bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one, and has the following structure:
[0074]
[0075] S5, crystallize 0.4g of the crude product of degradation impurities with ethyl acetate, and filter to obtain the finished product. The weight ratio of the crude product of degradation impurities to ethyl acetate is 1:6.5, and the specific crystallization steps are:
[0076] The crude degradation impurity product was dissolved in ethyl acetate, refluxed at 75°C for 30 min, then cooled to 25°C and slurried for 2 h, and then filtered to obtain the desired degradation impurity product (target product) with a purity of 91.04%. Its Chinese name is 2-methyl-6-[[(methyl)(thiophen-2-yl)amino]methyl]quinazolin-4(3H)-one, and has the following structure:
[0077]
[0078] The HPLC detection spectrum of the degradation impurity is shown in Figure 3 The molecular weight was confirmed to be 285.37, and the test data was consistent with the structure. The mass spectrum in positive ion mode is shown in Figure 4 , negative ion mode mass spectrum see Figure 5 , C NMR 13 C NMR Figure 6 , H NMR 1 H NMR Figure 7 .
[0079] Parts or structures not specifically described in the present invention may adopt existing technologies or existing products and will not be described in detail here.
[0080] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.
Claims
1. A raltitrexed degradation impurity, characterized in that: The Chinese name of the raltitrexed degradation impurity is 2-methyl-6-[[(methyl)(thiophen-2-yl)amino]methyl]quinazolin-4(3H)-one, which has the following structure:
2. A method for preparing raltitrexed by degrading impurities, characterized in that: The following steps are involved: S1, using thiophene-2-carboxylic acid as a starting material, reacting with diphenylphosphoryl azide to obtain impurity intermediate-1; S2, methylating the impurity intermediate-1 obtained in step S1 to obtain the impurity intermediate-2; S3, deprotecting the impurity intermediate-2 obtained in step S2 to obtain the impurity intermediate-3; S4, reacting the impurity intermediate-3 obtained in step S3 with compound A to obtain a crude product of degradation impurities; S5. The crude product of degraded impurities obtained in step S4 is crystallized with ethyl acetate and filtered to obtain a finished product.
3. The method for preparing raltitrexed degraded impurities according to claim 2, characterized in that: In step S1, the step of using thiophene-2-carboxylic acid as a starting material and reacting it with diphenylphosphoryl azide to obtain the impurity intermediate-1 comprises: Dissolve thiophene-2-carboxylic acid in tert-butanol, cool to below 25°C and then add alkali dropwise, then add diphenylphosphoryl azide dropwise, then heat to 60-100°C and react for 1-3h, then add purified water after the reaction, cool at 10-20°C and crystallize, then filter to obtain the impurity intermediate-1.
4. The method for preparing raltitrexed degraded impurities according to claim 3, characterized in that: The weight ratio of the thiophene-2-carboxylic acid to tert-butanol is 1:5-10; the base is triethylamine and / or N,N-diisopropylethylamine; the weight ratio of thiophene-2-carboxylic acid to diphenylphosphoryl azide is 1:2-5; the weight ratio of thiophene-2-carboxylic acid to purified water is 1:20-30.
5. The method for preparing raltitrexed degraded impurities according to claim 2, characterized in that: In step S2, the impurity intermediate-1 obtained in step S1 is subjected to methylation to obtain the impurity intermediate-2, comprising: The impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene and molecular sieves were dissolved in dichloromethane, cooled to 0-15°C and trimethyloxonium tetrafluoroborate was added, and the mixture was reacted at 0-30°C for 2-5h. After the reaction was completed, the mixture was filtered and the filtrate was dried to obtain the impurity intermediate-2.
6. The method for preparing raltitrexed degraded impurities according to claim 5, characterized in that: The weight ratio of the impurity intermediate-1, 1,8-bis(dimethylamino)naphthalene, molecular sieve and dichloromethane is 1:2.5-3:1-5:15-25; the weight ratio of the impurity intermediate-1 and trimethyloxonium tetrafluoroborate is 1:1.4-1.
8.
7. The method for preparing raltitrexed degraded impurities according to claim 1, characterized in that: In step S3, the impurity intermediate-2 obtained in step S2 is deprotected to obtain the impurity intermediate-3, comprising: Dissolve the impurity intermediate-2 in dichloromethane, cool to 0-10°C, then add acid dropwise, raise the temperature to 10-30°C and react for 1-3 hours. After the reaction is complete, concentrate to obtain the impurity intermediate-3; The weight ratio of the impurity intermediate-2 to dichloromethane is 1:5-8; The acid is hydrochloric acid and / or trifluoroacetic acid.
8. The method for preparing raltitrexed degraded impurities according to claim 2, characterized in that: In step S4, the step of reacting the impurity intermediate-3 obtained in step S3 with compound A to obtain a crude product of degraded impurities comprises: The impurity intermediate-3 was dissolved in N,N-dimethylformamide, the pH of the system was adjusted to 7-8, compound A and a base were added, the temperature was raised to 40-60°C and the reaction was performed for 5-10 hours. After the reaction was completed, purified water and dichloromethane were added for extraction, and the organic phase was concentrated to obtain a crude product of degradation impurities.
9. The method for preparing raltitrexed degraded impurities according to claim 8, characterized in that: The weight ratio of the impurity intermediate-3, compound A, N,N-dimethylformamide, and base is 1:0.5-1:8-12:0.2-0.5; the weight ratio of the impurity intermediate-3, dichloromethane, and purified water is 1:10-15:10-15; the Chinese name of the compound A is 6-bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one, which has the following structure:
10. The method for preparing raltitrexed degraded impurities according to claim 2, characterized in that: In step S5, the step of crystallizing the crude degraded impurity product obtained in step S4 with ethyl acetate and filtering to obtain the finished product comprises: The crude degradation impurity product is dissolved in ethyl acetate, wherein the weight ratio of the crude degradation impurity product to ethyl acetate is 1:5-10, and the product is first refluxed at 70-80°C for 30-60 minutes, then cooled to 20-30°C and pulped for 1-2 hours, and then filtered to obtain the finished product.
Citation Information
Patent Citations
Synthesis of anticancer medicine Raltiprexed
CN1486985A
Preparation of Leiliqusai
CN1552709A
Anti-tumour agents
US4992550A
